Digital Therapeutics for Neurological Disorders Market - 2026-2033
Digital Therapeutics for Neurological Disorders Market reached US$ 267.43 million in 2025 and is expected to reach US$ 504.36 million by 2033, growing with a CAGR of 8.30% during the forecast period 2026-2033.
The Digital Therapeutics for Neurological Disorders Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Digital Therapeutics for Neurological Disorders Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product Type
Both primary and secondary data sources have been used in the global Digital Therapeutics for Neurological Disorders Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Digital Therapeutics for Neurological Disorders Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Digital Therapeutics for Neurological Disorders Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product Type
- Software Therapeutics*
- Wearable Devices
- Neurodegenerative Disorders*
- Alzheimer’s Disease
- Parkinson’s Disease
- Multiple Sclerosis
- Huntington’s Disease
- Others
- Mental Health Disorders
- Depression
- Anxiety
- Post-Traumatic Stress Disorder
- Bipolar Disorder
- Obsessive-Compulsive Disorder (OCD)
- Stroke & Cerebrovascular Disorders
- Sleep Disorders
- Insomnia
- Sleep Apnea
- Cognitive Disorders
- Others
- Hospitals*
- Specialty Clinics
- Neuro-Rehabilitation Centers
- Homecare Settings
- Others
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Digital Therapeutics for Neurological Disorders Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
4. SNIPPET BY PRODUCT TYPE
4.1. Snippet by Disease Type
4.2. Snippet by End-User
4.3. Snippet by Region
5. DYNAMICS
5.1. Impacting Factors
5.1.1. Drivers
5.1.1.1. Shift Towards Home-Based Care & Remote Patient Monitoring
5.1.1.2. Rising Prevalence of Neurological Disorders
5.1.1.3. XX
5.1.2. Restraints
5.1.2.1. Data Privacy & Cybersecurity Concerns
5.1.2.2. Patient Adherence & Engagement Challenges
5.1.2.3. XX
5.1.3. Opportunity
5.1.3.1. Rising Technological Advancements
5.1.3.2. XX
5.1.4. Impact Analysis
6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established Leaders with Largest Selling Brand
6.1.3. Market Leaders with Established Product
6.2. CXO Perspectives
6.3. Latest Developments and Breakthroughs
6.4. Case Studies/Ongoing Research
6.5. Regulatory and Reimbursement Landscape
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East & Africa
6.6. Porter’s Five Force Analysis
6.7. Supply Chain Analysis
6.8. Patent Analysis
6.9. SWOT Analysis
6.10. Unmet Needs and Gaps
6.11. Recommended Strategies for Market Entry and Expansion
6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.13. Pricing Analysis and Price Dynamics
6.14. Key Opinion Leaders
7. DIGITAL THERAPEUTICS FOR NEUROLOGICAL DISORDERS MARKET, BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Software Therapeutics*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Wearable Devices
8. DIGITAL THERAPEUTICS FOR NEUROLOGICAL DISORDERS MARKET, BY DISEASE TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.1.2. Market Attractiveness Index, By Disease Type
8.2. Neurodegenerative Disorders*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Alzheimer’s Disease
8.2.4. Parkinson’s Disease
8.2.5. Multiple Sclerosis
8.2.6. Huntington’s Disease
8.2.7. Others
8.3. Mental Health Disorders
8.3.1. Depression
8.3.2. Anxiety
8.3.3. Post-Traumatic Stress Disorder
8.3.4. Bipolar Disorder
8.3.5. Obsessive-Compulsive Disorder (OCD)
8.3.6. Others
8.4. Stroke & Cerebrovascular Disorders
8.5. Sleep Disorders
8.5.1. Insomnia
8.5.2. Sleep Apnea
8.5.3. Others
8.6. Cognitive Disorders
8.7. Others
9. DIGITAL THERAPEUTICS FOR NEUROLOGICAL DISORDERS MARKET, BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Neuro-Rehabilitation Centers
9.5. Homecare Settings
9.6. Others
10. DIGITAL THERAPEUTICS FOR NEUROLOGICAL DISORDERS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
11. INTRODUCTION
11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.1. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.6.1. U.S.
11.2.6.2. Canada
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.6.1. Germany
11.3.6.2. U.K.
11.3.6.3. France
11.3.6.4. Spain
11.3.6.5. Italy
11.3.6.6. Rest of Europe
11.4. Latin America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.6.1. Mexico
11.4.6.2. Brazil
11.4.6.3. Argentina
11.4.6.4. Rest of Latin America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.6.1. China
11.5.6.2. India
11.5.6.3. Japan
11.5.6.4. South Korea
11.5.6.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
13. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
13.1. Market Share Analysis and Positioning Matrix
13.2. Strategic Partnerships, Mergers & Acquisitions
13.3. Key Developments in Product Portfolios and Innovations
13.4. Company Benchmarking
14. COMPANY PROFILES
14.1. Akili, Inc.*
14.1.1. Company Overview
14.1.2. Product Portfolio
14.1.2.1. Product Description
14.1.2.2. Product Key Performance Indicators (KPIs)
14.1.2.3. Historic and Forecasted Product Sales
14.1.2.4. Product Sales Volume
15. FINANCIAL OVERVIEW
15.1. Company Revenue’s
15.1.1. Geographical Revenue Shares
15.1.1.1. Revenue Forecasts
15.1.2. Key Developments
15.1.2.1. Mergers & Acquisitions
15.1.2.2. Key Product Development Activities
15.1.2.3. Regulatory Approvals, etc.
15.1.3. SWOT Analysis
15.2. Click Therapeutics, Inc.
15.3. BigHealth
15.4. Apple Inc.
15.5. MindMaze Inc
15.6. NeuroPace, Inc.
15.7. NeurologyToolKit
15.8. Matoph Labs e.U.
15.9. Fullpower Technologies, Inc.
15.10. Neybox Digital Ltd.LIST NOT EXHAUSTIVE
16. ASSUMPTION AND RESEARCH METHODOLOGY
16.1. Data Collection Methods
16.2. Data Triangulation
16.3. Forecasting Techniques
16.4. Data Verification and Validation
17. APPENDIX
17.1. About Us and Services
17.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
4. SNIPPET BY PRODUCT TYPE
4.1. Snippet by Disease Type
4.2. Snippet by End-User
4.3. Snippet by Region
5. DYNAMICS
5.1. Impacting Factors
5.1.1. Drivers
5.1.1.1. Shift Towards Home-Based Care & Remote Patient Monitoring
5.1.1.2. Rising Prevalence of Neurological Disorders
5.1.1.3. XX
5.1.2. Restraints
5.1.2.1. Data Privacy & Cybersecurity Concerns
5.1.2.2. Patient Adherence & Engagement Challenges
5.1.2.3. XX
5.1.3. Opportunity
5.1.3.1. Rising Technological Advancements
5.1.3.2. XX
5.1.4. Impact Analysis
6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
6.1. Market Leaders and Pioneers
6.1.1. Emerging Pioneers and Prominent Players
6.1.2. Established Leaders with Largest Selling Brand
6.1.3. Market Leaders with Established Product
6.2. CXO Perspectives
6.3. Latest Developments and Breakthroughs
6.4. Case Studies/Ongoing Research
6.5. Regulatory and Reimbursement Landscape
6.5.1. North America
6.5.2. Europe
6.5.3. Asia Pacific
6.5.4. Latin America
6.5.5. Middle East & Africa
6.6. Porter’s Five Force Analysis
6.7. Supply Chain Analysis
6.8. Patent Analysis
6.9. SWOT Analysis
6.10. Unmet Needs and Gaps
6.11. Recommended Strategies for Market Entry and Expansion
6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.13. Pricing Analysis and Price Dynamics
6.14. Key Opinion Leaders
7. DIGITAL THERAPEUTICS FOR NEUROLOGICAL DISORDERS MARKET, BY PRODUCT TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Software Therapeutics*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Wearable Devices
8. DIGITAL THERAPEUTICS FOR NEUROLOGICAL DISORDERS MARKET, BY DISEASE TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
8.1.2. Market Attractiveness Index, By Disease Type
8.2. Neurodegenerative Disorders*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Alzheimer’s Disease
8.2.4. Parkinson’s Disease
8.2.5. Multiple Sclerosis
8.2.6. Huntington’s Disease
8.2.7. Others
8.3. Mental Health Disorders
8.3.1. Depression
8.3.2. Anxiety
8.3.3. Post-Traumatic Stress Disorder
8.3.4. Bipolar Disorder
8.3.5. Obsessive-Compulsive Disorder (OCD)
8.3.6. Others
8.4. Stroke & Cerebrovascular Disorders
8.5. Sleep Disorders
8.5.1. Insomnia
8.5.2. Sleep Apnea
8.5.3. Others
8.6. Cognitive Disorders
8.7. Others
9. DIGITAL THERAPEUTICS FOR NEUROLOGICAL DISORDERS MARKET, BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Clinics
9.4. Neuro-Rehabilitation Centers
9.5. Homecare Settings
9.6. Others
10. DIGITAL THERAPEUTICS FOR NEUROLOGICAL DISORDERS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
11. INTRODUCTION
11.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.1. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.6.1. U.S.
11.2.6.2. Canada
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.6.1. Germany
11.3.6.2. U.K.
11.3.6.3. France
11.3.6.4. Spain
11.3.6.5. Italy
11.3.6.6. Rest of Europe
11.4. Latin America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.6.1. Mexico
11.4.6.2. Brazil
11.4.6.3. Argentina
11.4.6.4. Rest of Latin America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.6.1. China
11.5.6.2. India
11.5.6.3. Japan
11.5.6.4. South Korea
11.5.6.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
13. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
13.1. Market Share Analysis and Positioning Matrix
13.2. Strategic Partnerships, Mergers & Acquisitions
13.3. Key Developments in Product Portfolios and Innovations
13.4. Company Benchmarking
14. COMPANY PROFILES
14.1. Akili, Inc.*
14.1.1. Company Overview
14.1.2. Product Portfolio
14.1.2.1. Product Description
14.1.2.2. Product Key Performance Indicators (KPIs)
14.1.2.3. Historic and Forecasted Product Sales
14.1.2.4. Product Sales Volume
15. FINANCIAL OVERVIEW
15.1. Company Revenue’s
15.1.1. Geographical Revenue Shares
15.1.1.1. Revenue Forecasts
15.1.2. Key Developments
15.1.2.1. Mergers & Acquisitions
15.1.2.2. Key Product Development Activities
15.1.2.3. Regulatory Approvals, etc.
15.1.3. SWOT Analysis
15.2. Click Therapeutics, Inc.
15.3. BigHealth
15.4. Apple Inc.
15.5. MindMaze Inc
15.6. NeuroPace, Inc.
15.7. NeurologyToolKit
15.8. Matoph Labs e.U.
15.9. Fullpower Technologies, Inc.
15.10. Neybox Digital Ltd.LIST NOT EXHAUSTIVE
16. ASSUMPTION AND RESEARCH METHODOLOGY
16.1. Data Collection Methods
16.2. Data Triangulation
16.3. Forecasting Techniques
16.4. Data Verification and Validation
17. APPENDIX
17.1. About Us and Services
17.2. Contact Us
